Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
LIOCYXM-004 by Lion TCR for Hepatocellular Carcinoma: Likelihood of Approval
LIOCYXM-004 is under clinical development by Lion TCR and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData, Phase...
Data Insights
Fostroxacitabine bralpamide hydrochloride by Medivir for Hepatocellular Carcinoma: Likelihood of Approval
Fostroxacitabine bralpamide hydrochloride is under clinical development by Medivir and currently in Phase II for Hepatocellular Carcinoma. According to GlobalData,...